Syneron Medical Ltd. is proud to announce it has received United States Food and Drug Administration (FDA) clearance for elōs Plus™, a next generation multi-platform system featuring the Company's proprietary elōs technology. The FDA clearance for elōs Plus follows on the recent international launch in Europe and Asia. Want to read more? Subscribe to one of our monthly plans to continue reading this article.